• About WordPress
    • WordPress.org
    • Documentation
    • Learn WordPress
    • Support
    • Feedback
  • Log In
  • Register
Skip to main content
RxHarun
Login / Register Login/Signup
  • Health (A – Z)
  • Drugs (A – Z)
  • Rx Cancer (A – Z)
  • Rx Neurology (A – Z)
  • Rx Urology
  • Rx Lab Test (A – Z)
  • Rx Shop (A – Z)
  • Rx iT World
  • Rx Foundation
...

Ketorolac Contraindications, Pregnancy Category

7 Views
Drugs (A - Z)
  • Ketorolac Indications
  • Ketorolac Contraindications
  •  Dosage of Ketorolac
  • Side Effects of Ketorolac
  • Drug Interactions of Ketorolac
  • Pregnancy & Lactation of Ketorolac
Ketorolac Contraindications is a synthetic pyrrolizine carboxylic acid derivative with anti-inflammatory, analgesic, and antipyretic activities. Ketorolac non-selective inhibits the enzymes cyclooxygenase 1 (COX-1) and COX-2. The inhibition of COX-2, up-regulated at sites of inflammation, prevents the conversion of arachidonic acid to pro-inflammatory prostaglandins. The inhibition of COX-1 by this agent prevents the normal steady-state production of prostaglandins that play housekeeping roles in the protection of the gastrointestinal tract, the regulation of renal blood flow, and platelet aggregation. As a result, the inhibition of COX-1 may be associated with gastrointestinal toxicity, nephrotoxicity, and the inhibition of platelet aggregation.
Ketorolac is a potent, short-acting nonsteroidal anti-inflammatory drug (NSAID) that is available in both parenteral and oral forms. Ketorolac is generally given for a few days only and has not been linked to instances of idiosyncratic drug-induced liver disease in the published literature.

Ketorolac Indications

  • For the short-term (5 days) management of moderately severe acute pain that requires analgesia at the opioid level, usually in a postoperative setting.
  • Pain due to road traffic accident.
  • Postoperative pain
  • Acute dental pain
  • Acute pain due to trauma
  • Accidental pain
  • Acute abdominal pain due to gastritis/appendicitis
  • Ankylosing spondylitis
  • Pain due to especially musculoskeletal system
  • Lumbago
  • Low back pain
  • PLID
  • Polyarthralgia
  • Cystoid macular edema
  • Inflammatory reaction
  • A migraine, acute
  • Ocular itching
  • Ocular pain
  • Pseudophakic cystoid macular edema
  • Acute pericarditis
  • Chronic aphakic cystoid macular edema
  • Intraoperative miosis
  • Moderate acute pain
  • Severe acute pain

Ketorolac Contraindications

  • Allergy to tramadol hydrochloride or any other ingredients in the medicine;
  • Allergy to medicines called opioid antagonists (e.g. codeine, morphine);
  • Consumed alcohol taken another drug which affects your brain. These include:
  • Some painkillers, including opioid painkillers;
  • Hypnotic drugs;
  • Psychotropic drugs;
  • Used monoamine oxidase inhibitors (MAOIs) such as phenelzine or tranylcypromine
  • Epilepsy;
  • Addiction or are recovering from addiction to another medication.
  • History of peptic ulcer disease,
  • Gastrointestinal bleeding,
  • Alcohol intolerance,
  • Renal impairment,
  • Cerebrovascular bleeding,
  • Nasal polyps,
  • Angioedema, and asthma
  • Acute intoxication with alcohol,
  • Hypnotics,
  • Heart failure,
  • Coagulation disorders,
  • Renal impairment,
  • Hepatic impairment.

 Dosage of Ketorolac

Strengths: 10 mg; 15 mg/mL; 30 mg/mL; 60 mg/2 mL

Dose for Pain

The combined duration of use of parenteral, oral, and intranasal ketorolac should not exceed 5 days; the oral formulation is only to be used as the continuation to IV or IM therapy.

Intranasal

  • Weight 50 kg or more: 31.5 mg every 6 to 8 hours (1 spray in each nostril)
  • Weight less than 50 kg: 15.75 mg every 6 to 8 hours (1 spray in 1 nostril)
  • Maximum dose: 4 doses per day

Parenteral, Single-Dose Treatment

  • Weight 50 kg or more: 60 mg IM or 30 mg IV
  • Weight less than 50 kg: 30 mg IM or 15 mg IV

Multiple-Dose Treatment

  • Weight 50 kg or more: 30 mg IM/IV every 6 hours as needed
  • Maximum dose: 120 mg/day
  • Weight less than 50 kg: 15 mg IM/IV every 6 hours as needed
  • Maximum dose: 60 mg/day

Oral, as the continuation to parenteral therapy

  • Weight 50 kg or more: 20 mg orally once followed by 10 mg every 4 to 6 hours as needed
  • Weight less than 50 kg: 10 mg orally once followed by 10 mg every 4 to 6 hours as needed
  • Maximum dose: 40 mg/day

Geriatric Pain

The combined duration of use of parenteral, oral, and intranasal ketorolac should not exceed 5 days; the oral formulation is only to be used as the continuation to IV or IM therapy.

Intranasal

  • Dose: 15.75 mg every 6 to 8 hours (one spray in 1 nostril)
  • Maximum dose: 4 doses per day

Parenteral

  • Single-Dose Treatment: 30 mg IM or 15 mg IV
  • Multiple-Dose Treatment: 15 mg IM/IV every 6 hours as needed
  • Maximum dose: 60 mg/day

Oral, as the continuation to parenteral therapy

  • Dose: 10 mg orally once followed by 10 mg every 4 to 6 hours as needed
  • Maximum dose: 40 mg/day

Pediatric Pain

The combined duration of use of parenteral, oral, and intranasal ketorolac should not exceed 5 days; the oral formulation is only to be used as continuation therapy to IV or IM.

Intranasal Age: Greater than 17 years

  • Weight 50 kg or more: 31.5 mg every 6 to 8 hours (1 spray in each nostril)
  • Weight less than 50 kg: 15.75 mg every 6 to 8 hours (1 spray in 1 nostril)
  • Maximum: 4 doses per day

Oral, as the continuation of parenteral therapy, Age: 17 years or older

  • Weight 50 kg or more: 20 mg orally once followed by 10 mg every 4 to 6 hours as needed
  • Weight less than 50 kg: 10 mg orally once followed by 10 mg every 4 to 6 hours as needed
  • Maximum dose: 40 mg/day

Parenteral Age: 17 years or older

  • Single-Dose Treatment:
  • Weight 50 kg or more: 60 mg IM or 30 mg IV
  • Weight less than 50 kg: 30 mg IM or 15 mg IV

Multiple-Dose Treatment

  • Weight 50 kg or more: 30 mg IM/IV every 6 hours as needed
  • Maximum dose: 120 mg/day
  • Weight less than 50 kg: 15 mg IM/IV every 6 hours as needed
  • Maximum dose: 60 mg/day

Age: 2 to 16 years, Single-Dose Treatment

  • IM: 1 mg/kg up to a maximum of 30 mg
  • IV: 0.5 mg/kg up to a maximum of 15 mg
  • Maximum dose: 1 dose

Side Effects of Ketorolac

The most common

  • GI disorders (e.g. dyspepsia, abdominal pain, nausea, vomiting, diarrhea, flatulence, constipation,, ulcerative stomatitis, ), indigestion,
  • Disturbances of the gut such as diarrhea, constipation, nausea, vomiting or abdominal pain.
  • Drowsiness and lightheadedness
  • Nausea and vomiting
  • joint pain
  • Nausea and vomiting
  • Severe stomach ache
  • Severe diarrhea
  • Vaginal thrush
  • Skin rash
  • A headache
  • Chest pain
  • Diarrhea or loose stools
  • Difficulty with breathing
  • Dizziness
  • Heartburn
  • Muscle pain

More common

  • Abdominal or stomach pain,
  • Chills or fever
  • A headache,
  • Joint or back pain
  • Muscle aching or cramping
  • Muscle pains or stiffness
  • Chest pressure or squeezing pain in the chest
  • Excessive sweating
  • feeling of heaviness, pain, warmth and/or swelling in a leg or in the pelvis
  • sudden tingling or coldness in an arm or leg
  • Constipation
  • Diarrhea
  • Loss of muscle coordination
  • Sleepiness or unusual drowsiness
  • Clumsiness or unsteadiness
  • Drowsiness

Rare

  • Anxiety
  • change in vision
  • seizures
  • abnormal or fast heart rate
  • tremors
  • weight loss
  • chest pain or tightness
  • confusion
  • a cough
  • Agitation
  • arm, back, or jaw pain
  • blurred vision
  • chest pain or discomfort
  • convulsions
  • extra heartbeats
  • fainting
  • hallucinations
  • a headache
  • irritability
  • lightheadedness
  • mood or mental changes
  • muscle pain or cramps
  • muscle spasm or jerking of all extremities
  • muscle pains or stiffness
  • chest pressure or squeezing pain in the chest
  • discomfort in arms, shoulders, neck or upper back

Drug Interactions of Ketorolac

Ketorolac may interact with following drugs, supplements & may change the efficacy of drugs

  • aminoglycoside antibiotics (e.g., amikacin, gentamicin, tobramycin)
  • angiotensin-converting enzyme inhibitors (ACEIs; e.g., captopril, enalapril, ramipril)
  • angiotensin receptor blockers (ARBs; e.g., candesartan, irbesartan, losartan)
  • beta-adrenergic blockers (e.g., metoprolol, atenolol)
  • calcium channel blockers (e.g., amlodipine, diltiazem, nifedipine, verapamil)
  • celecoxib
  • cilostazol
  • clopidogrel
  • corticosteroids (e.g., dexamethasone, hydrocortisone, prednisone)
  • cyclosporine
  • diuretics (water pills; e.g., furosemide, hydrochlorothiazide, triamterene)
  • 5-ASA medications (e.g, sulfasalazine)
  • glucosamine
  • haloperidol
  • heparin
  • methotrexate
  • multivitamins
  • other non-steroidal anti-inflammatory medications (NSAIDs; e.g., diclofenac, ibuprofen, ketorolac, naproxen)
  • Omega-3 fatty acids
  • pentoxifylline
  • quinolone antibiotics (e.g., ciprofloxacin, ofloxacin)
  • selective serotonin reuptake inhibitors (SSRIs; e.g., citalopram, duloxetine,fluoxetine, paroxetine, sertraline)
  • serotonin/norepinephrine reuptake inhibitors (SNRIs; e.g, duloxetine, )
  • tricyclic antidepressants (e.g., amitriptyline, clomipramine, desipramine, trimipramine)
  • warfarin

Pregnancy & Lactation of Ketorolac

FDA Pregnancy Category C

Pregnancy

This medication should not be used during pregnancy unless the benefits outweigh the risks. If you become pregnant while taking this medication, contact your doctor immediately. It must not be used during the last 3 months of pregnancy as it may cause heart and kidney problems for the developing baby and cause prolonged labor with excessive bleeding during delivery.

Breastfeeding

This medication passes into breast milk. If you are a breastfeeding mother and are taking ketorolac, it may affect your baby. Breastfeeding is not recommended while you are taking ketorolac.

References

  1. Burnham Center for Chemical Genomics
    https://pubchem.ncbi.nlm.nih.gov/bioassay/1996#section=Data-Table
  2. Sanford-Burnham Center for Chemical Genomics
    https://pubchem.ncbi.nlm.nih.gov/bioassay/1996#section=Data-Table
  3. ChemIDplus
    https://chem.nlm.nih.gov/chemidplus/sid/0074103074
    https://chem.sis.nlm.nih.gov/chemidplus/chemidheavy.jsp
  4. DTP/NCI
    https://dtp.cancer.gov/dtpstandard/servlet/dwindex?searchtype=NSC&outputformat=html&searchlist=758637
  5. ClinicalTrials.gov
    https://clinicaltrials.gov/
  6. DailyMed
    https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=KETOROLAC+TROMETHAMINE
    https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=OMIDRIA
  7. European Chemicals Agency (ECHA)
    https://echa.europa.eu/information-on-chemicals/cl-inventory-database/-/discli/details/154008
  8. FDA Medication Guides
    https://www.fda.gov/downloads/Drugs/DrugSafety/ucm089165.pdf
  9. FDA Orange Book
    /Drugs/InformationOnDrugs/ucm129662.htm
  10. MassBank of North America (MoNA)
    http://mona.fiehnlab.ucdavis.edu/spectra/browse?inchikey=BWHLPLXXIDYSNW-UHFFFAOYSA-N
  11. NCIT
    https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=NCI_Thesaurus&code=C61798
  12. PubMed Health
    http://www.ncbi.nlm.nih.gov/pubmedhealth/PMHT0010834/
    http://www.ncbi.nlm.nih.gov/pubmedhealth/PMHT0001020/
    http://www.ncbi.nlm.nih.gov/pubmedhealth/PMHT0010835/
  13. SpectraBase
    https://spectrabase.com/spectrum/1WllfPWDXmZ
    https://spectrabase.com/spectrum/EkL8c30niKl
  14. Springer Nature
     Read more …
  15. Wikipedia
    https://www.wikidata.org/wiki/Q27107089

    https://pubchem.ncbi.nlm.nih.gov

  16. MeSH
    https://www.ncbi.nlm.nih.gov/mesh/68020911
    http://www.nlm.nih.gov/mesh/meshhome.html
    https://www.ncbi.nlm.nih.gov/mesh/68000894
    https://www.ncbi.nlm.nih.gov/mesh/68016861
  17. KEGG
    http://www.genome.jp/kegg-bin/get_htext?br08302.keg
    http://www.genome.jp/kegg-bin/get_htext?br08303.keg
    http://www.genome.jp/kegg-bin/get_htext?br08310.keg
    http://www.genome.jp/kegg-bin/get_htext?br08330.keg
  18. https://pubchem.ncbi.nlm.nih.gov/compound/Ketorolac_tromethamine
  19. WIPO
    http://www.wipo.int/classifications/ipc/
  20. WHO ATC
    https://www.whocc.no/atc_ddd_index/
  21. ChEMBL
    https://www.ebi.ac.uk/chembl/target/browser
  22. https://www.drugs.com/ppa/ketorolac-systemic.html

    https://www.ncbi.nlm.nih.gov/projects/linkout

Ketorolac Contraindications

SaveSavedRemoved 0
Ketorolac Contraindications, Pregnancy Category
Previous

Ketorolac Indications, Contraindications, Warning

Ketorolac Contraindications, Pregnancy Category
Next

Tramadol Indications, Contraindications, Warning

Related Articles
Added to wishlistRemoved from wishlist 0
Vasodilator Drugs

Vasodilator Drugs

Added to wishlistRemoved from wishlist 0
Methamphetamine

Methamphetamine Hydrochloride – Uses, Dosage, Side Effects, Interaction

Added to wishlistRemoved from wishlist 0
Methamphetamine – Uses, Dosage, Side Effects, Interactions

Methamphetamine – Uses, Dosage, Side Effects, Interactions

Added to wishlistRemoved from wishlist 0
Vitamin D3 – Uses, Dosage, Side Effects, Interactions

Vitamin D3 – Uses, Dosage, Side Effects, Interactions

Sign up for our free Good Health Newsletter!

We don’t spam! Read our privacy policy for more info.

Check your inbox or spam folder to confirm your subscription.

About Rehub

This demo site is only for demonstration purposes. All images are copyrighted to their respective owners. All content cited is derived from their respective sources. Credits

How to Make Custom Footer Area Via Page Builder

test@test.com
3800003030

About Rehub

Re:Hub is modern all in one price comparison and review theme with best solutions for affiliate marketing. This demo site is only for demonstration purposes. All images are copyrighted to their respective owners. All content cited is derived from their respective sources.

How to Make Custom Footer Area Via Page Builder

Terms and Conditions of Use Privacy Policy Cookie Policy Editorial Policy Advertising Policy Correction Policy
Contact us About us Newsletter Career Sitemap
Advertise with us
Rx Team
  • Editorial Board Members
  • Review Board Member
  • Team Rxharun
  • Web Developers Team
  • Guest Posts and Sponsored Posts
  • Request for Board Member
Authority
  • Contact us
  • About us
  • Newsletter
  • Career
  • Sitemap
For customers
  • First link
  • Second Link
  • Third link
  • Fourth link
For vendors
  • First link
  • Second Link
  • Third link
  • Fourth link

Mobile Application

Follow Rxharun on Social Media
Sign Up for Weekly Newsletter

Investigationes demonstraverunt lectores legere me lius quod ii legunt saepius.

Custom links
  • First link
  • Second Link
  • Third link
  • Fourth link
Custom section
  • First link
  • Second Link
  • Third link
  • Fourth link
RxHarun
Logo
Register New Account
Already have an account? Login
Log In
Lost Password?
Don't have an account? Sign Up

RxHarun

AI Chat Bot

Dorian

Hey, how can I help you today?

Powered by Elementor

Click to start chat